Why is age the single biggest risk factor for neurodegeneration? For years the answer has centered on four suspects: DNA damage, failing protein quality control, tired mitochondria and chronic inflammation. In a new review, UCSD graduate student Sawyer Randles and Professor Gene Yeo, Sanford Labs’ Chief Scientist and Co-Founder, make the case for a fifth that deserves equal billing — RNA.
Neurons are among the longest-lived cells in the body, and they depend on an enormous amount of RNA regulation to stay functional: getting the right transcript to the right place, at the right moment, in the right amount. That regulation is run by RNA-binding proteins (RBPs), and it is not static. As we age, RBP levels shift, they end up in the wrong cellular compartments, their biophysical behavior changes and the RNAs they grip change with them.
The result is a slow erosion of RNA regulatory fidelity. RNP granules — the dynamic, reversible assemblies neurons use to store and traffic RNA — become less reversible, which ties RNA dysregulation directly to the protein aggregation we see in disease.
The central argument here is that this age-dependent RNA dysregulation isn’t a side effect. It converges with inherited genetic risk on the same RNA-centered pathways. A variant you’ve carried your whole life may only become consequential once the aging RNA machinery can no longer buffer it.
If that’s right, RNA homeostasis becomes a therapeutic axis for brain health across the lifespan — not just a readout of damage already done.